Global Intensity Modulated Radiation Therapy Market Size, Share, and COVID-19 Impact Analysis, By Radiation Type (Proton Radiation, Electron Radiation, Photon Radiation, and Carbon-ion Radiation), By Application (Prostate Cancer, Lung Cancer, Breast Cancer, Brain Cancer, and Gynecological Cancer), By End-User (Hospital and Standalone Radiation Therapy Center), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.
Industry: HealthcareGlobal Intensity Modulated Radiation Therapy Market Insights Forecasts to 2033
- The Global Intensity Modulated Radiation Therapy Market Size was Valued at USD 2.4 Billion in 2023
- The Market Size is Growing at a CAGR of 5.40% from 2023 to 2033
- The Worldwide Intensity Modulated Radiation Therapy Market Size is Expected to Reach USD 4.06 Billion by 2033
- Asia Pacific is Expected to Grow the fastest during the forecast period.
Get more details on this report -
The Global Intensity Modulated Radiation Therapy Market Size is Anticipated to Exceed USD 4.06 Billion by 2033, Growing at a CAGR of 5.40% from 2023 to 2033.
Market Overview
IMRT, or intensity-modulated radiation therapy, is a sophisticated form of radiation treatment. Strong energy beams are used in radiation therapy to destroy cancer cells. Protons, X-rays, and other sources are possible sources of the energy. The radiation beams used in IMRT are precisely tailored. The beams are designed to resemble the cancer's form. While delivering the radiation, the beams are able to travel in an arc. Each beam's intensity can be changed. A precisely regulated radiation therapy is the end consequence. The right radiation dosage is administered by IMRT as effectively and safely as possible. The radiation beams used in IMRT are precisely tailored. The beams are designed to resemble the cancer's form. While delivering the radiation, the beams are able to travel in an arc. Each beam's intensity can be changed. A precisely regulated radiation therapy is the end consequence. Both cancers and benign (also known as non-cancerous) tumors can be treated with IMRT. Anywhere in the body, tumors and malignancies can be treated with it. The aim of IMRT is to deliver an accurate dose of radiation to the target and reduce radiation outside of the target. This provides a lower risk of damaging nearby healthy tissue. The generally occurring cancers are prostate cancer, melanoma, breast cancer, and others. Thus, rushing cancer patients is predicted to increase the overall business progress.
Report Coverage
This research report categorizes the market for the global intensity modulated radiation therapy market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global intensity modulated radiation therapy market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global intensity modulated radiation therapy market.
Global Intensity Modulated Radiation Therapy Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2023 |
Market Size in 2023: | USD 2.4 Billion |
Forecast Period: | 2023-2033 |
Forecast Period CAGR 2023-2033 : | 5.40% |
2033 Value Projection: | USD 4.06 Billion |
Historical Data for: | 2019-2022 |
No. of Pages: | 190 |
Tables, Charts & Figures: | 120 |
Segments covered: | By Radiation Type, By Application, By End-User, By Region |
Companies covered:: | Mevion Medical Systems, Siemens Healthcare GmbH, IBA Worldwide, Koninklijke Philips N.V., Hitachi, Ltd., CIVCO Medical Solutions, Elekta AB, Optivus Proton Therapy, Inc., Nordion, Inc., Curium, Varian Medical Systems, Inc., ViewRay Technologies, Inc., Accuray Incorporated, Eckert & Ziegler, and other key vendors |
Pitfalls & Challenges: | COVID-19 Empact, Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The IMRT market is significantly driven by the rising incidence of cancer worldwide. The need for efficient and focused radiation therapy techniques, such as IMRT, is rising along with the number of cancer cases. As a result, the market for intensity-modulated radiation treatment is driven by several reasons, such as the expanding use of IMRT in emerging economies as a result of rising healthcare expenditures and the development of infrastructure in these areas. Furthermore, two major drivers driving market expansion are the aging population and the increased prevalence of cancer. These are the specific factors that support market expansion. In addition, favorable reimbursement arrangements for radiation treatments, including IMRT, are found in many wealthy countries. Patients are encouraged to choose cutting-edge and successful therapies like IMRT with this financial assistance.
Restraining Factors
Purchasing and setting up IMRT equipment can be costly. This expense can be an important barrier for healthcare facilities, especially in areas with limited resources. As a result, IMRT services may not be as widely available, which is predicted to hinder market expansion. Furthermore, it is anticipated that the market for intensity-modulated radiation treatment will face obstacles during the forecast period due to a shortage of highly qualified radiation oncologists, medical physicists, and radiation therapists. These factors restrain the growth of the global intensity modulated radiation therapy market.
Market Segmentation
The global intensity modulated radiation therapy market share is classified into radiation type, application, and end-user.
- The proton radiation segment is anticipated to hold the largest share of the global intensity modulated radiation therapy market during the forecast period.
On the basis of the radiation type, the global intensity modulated radiation therapy market is divided into proton radiation, electron radiation, photon radiation, and carbon-ion radiation. Among these, the proton radiation segment is anticipated to hold the largest share of the global intensity modulated radiation therapy market during the forecast period. Proton therapy provides some advantages; its use is often studied in particular clinical scenarios; and the choice of treatment mode depends on factors like the type and location of the tumor, the patient's overall health, and the aim of the treatment. Continuous advancements in proton radiation, which involve pencil beam scanning and intensity-modulated proton therapy (IMPT), grant improved treatment accuracy and the capacity to deliver highly consistent doses of radiation. Hence, the rising adoption of proton radiation and increasing healthcare expenditure contribute to the growth of the market.
- The brain cancer segment is anticipated to hold the highest share of the global intensity modulated radiation therapy market during the forecast period.
On the basis of the application, the global intensity modulated radiation therapy market is divided into prostate cancer, lung cancer, breast cancer, brain cancer, and gynecological cancer. Among these, the brain cancer segment is anticipated to hold the highest share of the global intensity modulated radiation therapy market during the forecast period. The continuous patient interest in non-surgical cancer treatment is contributing to the larger segmental growth over other IMRT applications. Furthermore, the increasing cases of brain cancer and the developed radiotherapy equipment in the world are predicted to drive the demand in the study period.
- The hospital segment is anticipated to hold the largest share of the global intensity modulated radiation therapy market during the forecast period.
On the basis of end-user, the global intensity modulated radiation therapy market is divided into hospital and standalone radiation therapy center. Among these, the hospital segment is anticipated to hold the largest share of the global intensity-modulated radiation therapy market during the forecast period. The expansion is attributable to the availability of emergency facilities, well-developed healthcare facilities, and the presence of trained healthcare professionals. A growing number of patients visiting hospitals for successful treatment and better infrastructure will result in higher segment development. Hospitals are equipped with highly advanced technological products and provide a base for most of the surgeries achieved globally, hence improving patient results and favoring market growth.
Regional Segment Analysis of the Global Intensity Modulated Radiation Therapy Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America is anticipated to hold the largest share of the global intensity modulated radiation therapy market over the predicted timeframe.
Get more details on this report -
North America is anticipated to hold the largest share of the global intensity-modulated radiation therapy market over the predicted timeframe. The increasing cases of cancer in the U.S. contribute to the increased demand for advanced and effective cancer treatment methods. In addition, the availability of advanced healthcare infrastructure, such as those equipped with cutting-edge radiation therapy equipment, will propel the adoption of IMRT. Key medical centers and cancer treatment facilities in the U.S. are more likely to provide advanced treatment options, like intensity-modulated radiation therapy. In addition, the presence of some market participants focusing on developing novel products for better patient management will prove advantageous for market growth.
Asia-Pacific is anticipated to grow at the fastest rate in the global intensity-modulated radiation therapy market over the predicted timeframe. A number of factors are causing the market in the region to rise rapidly. This can be linked to factors like increased patient numbers, rising healthcare infrastructure spending, and expanding knowledge of the advantages of radiation therapy. China and India, in particular, are experiencing significant expansion in the market because of their enormous populations and initiatives to upgrade cancer treatment facilities. Additionally, the demand for radiation in the area is being driven by growing disposable incomes and increased accessibility to healthcare facilities. These factors drive the growth of the intensity-modulated radiation therapy market over the predicted timeframe in this region.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global intensity modulated radiation therapy market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Mevion Medical Systems
- Siemens Healthcare GmbH
- IBA Worldwide
- Koninklijke Philips N.V.
- Hitachi, Ltd.
- CIVCO Medical Solutions
- Elekta AB
- Optivus Proton Therapy, Inc.
- Nordion, Inc.
- Curium
- Varian Medical Systems, Inc.
- ViewRay Technologies, Inc.
- Accuray Incorporated
- Eckert & Ziegler
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In July 2023, Apollo Hospitals introduced its scheme to develop two more proton cancer centers in India.
- In June 2022, Accuracy opens up a strategic partnership with Limbus AI to bolster adaptive radiotherapy solutions. This collaboration marked a notable breakthrough in growing Accuray’s product portfolio and demonstrating the company’s commitment to advancing advanced technologies in the area of radiotherapy.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global intensity modulated radiation therapy market based on the below-mentioned segments:
Global Intensity Modulated Radiation Therapy Market, By Radiation Type
- Proton Radiation
- Electron Radiation
- Photon Radiation
- Carbon-ion Radiation
Global Intensity Modulated Radiation Therapy Market, By Application
- Prostate Cancer
- Lung Cancer
- Breast Cancer
- Brain Cancer
- Gynecological Cancer
Global Intensity Modulated Radiation Therapy Market, By End-User
- Hospital
- Standalone Radiation Therapy Center
Global Intensity Modulated Radiation Therapy Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
Need help to buy this report?